Healthcare professionals' behavior change in clinical practice Not Applicable
Conditions
Interventions
Feasibility study with before-and-after design with focus on exploring an implementation intervention directed to healthcare professionals in primary healthcare centers, where a combination of methods
an introductory half-day seminar and two follow-up one-hour seminars during six months. The study researcher (PI) surveys the intervention process at working team meetings and all seminars. A research
Sponsors
Center for Clinical Research Dalarna, County Council of Dalarna (Sweden)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: At each participating primary healthcare center, all licensed healthcare professionals having consultations with adult patients who may have a need for increased level of health-promoting physical activity, as well as the healthcare center management (the manager and possibly others in supervisory positions), participate in the intervention.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This is a pilot study with the primary aim to explore the feasibility and acceptability of the intervention, not to evaluate an ‘a priori’ primary outcome measure. Study evaluation will be targeting the implementation process and mechanisms of change. Baseline measurement: the healthcare staff's use of and attitudes toward prescribing FaR (i.e. appreciation of the content, objective and evidence base for the method, as well as trust in the effects of the method, etc) will be measured by a questionnaire prior to the intervention. Also the quality of the FaR-prescriptions (i.e. the use of the five components included in FaR) will be measured by the questionnaire to the healthcare staff. Follow-up measurements: of healthcare staff's use of and attitudes towards FaR, as well as of the quality of FaR-prescriptions is done through questionnaires and semi-structured interviews (focus groups, respectively individual interviews) after the intervention, i.e. at the last intervention seminar (just before 6 months), respectively, at 6 months after the intervention. Process evaluation: observation protocols at all intervention seminars/workshops including checklists of intervention components and notations of deviation from the intervention protocol. | — |
Secondary
| Measure | Time frame |
|---|---|
| Data will also be collected for the purpose of evaluating methods for data collection in a full-scale randomized controlled study on the outcome measure: effects on behaviour change in prescribing FaR. Baseline measurement: The quantity of FaR-prescriptions (i.e. the number of registered prescriptions) at each primary healthcare center will be registered during a month prior to the intervention, through statistics from the patient medical records. Follow-up measurements: of the quantity of FaR-prescriptions for every month throughout the year, i.e. until one year after the intervention. To eliminate seasonal variations in FaR-prescriptions, measurement and comparison will be undertaken between the same months in two consecutive years; for example April 2016 will be compared to April 2017. Data collection will be completed a year after the intervention. | — |
Countries
Sweden
Outcome results
None listed